Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 3, 2013

View Archived Issues

HDL mimetic peptide exerts cardioprotective activity and reduces atherosclerosis

Pneumonia case accrual completed for CAPiTA study of Prevenar 13

Seattle Genetics patents new monoclonal antibodies

New IL-1 beta antibodies disclosed by researchers in Singapore

New NIK inhibitors patented by Roche and Genentech

Favorable phase I trial results reported for novel anti-PSCK9 monoclonal antibody

BioTime cleared to begin human studies with Renevia

South African and Swiss teams claim new agents for malaria

U.S. and Hong Kong researchers disclose novel polypeptides for muscle disorders

Redbiotec and TeselaGen to collaborate on Herpes virus vaccine library

Sinupret dry extract demonstrates antiviral and anti-inflammatory activity

Astellas and MSD sign copromotion agreement for ipragliflozin in Japan

Heidelberg Pharma and Roche sign license agreement for antibody-targeted amanitin conjugates

U.K.'s NICE recommends NHS reimbursement for Jetrea

Benefit seen with ATX-MS-1467 in phase I multiple sclerosis trial

Susceptibility loci for hypertension identified in Japanese subjects

Polymorphism on chromosome 9p21 linked to prognosis after myocardial infarction

University of Warwick researcher wins drug discovery award from Domainex

Swissmedic opposes approval of Vitaros

Akorn to acquire Hi-Tech Pharmacal

World Health Organization prequalifies Menomune meningococcal vaccine

InVivo Therapeutics outlines development plan for spinal cord injury program

Initiation of phase I trial of PF-06263507 triggers milestone payment

Presidio Pharmaceuticals begins phase I hepatitis C study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...